ExpreS2ion Biotech Holding AB Sustainability Reports
ExpreS2ion Biotech Holding AB is a biotechnology enterprise that develops innovative vaccines and active immunotherapies for cancer and infectious diseases. The company utilizes its proprietary ExpreS2 protein expression platform to produce complex proteins for vaccine development, diagnostic purposes, and research collaborations.
Sector: Professional & technical services
Country: Sweden
Exchange: Nasdaq Stockholm
LEI: 549300FJK50P1ORYJC45
FIGI: BBG00D3JNGT4
3 reports from 2023 to 2025
